Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release.

Drug metabolism and pharmacokinetics

Volumn 20, Issue 3, 2005, Pages 187-199

  Matsui Sakata, Akiko ^a   Ohtani, Hisakazu ^a   Sawada, Yasufumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOZAPINE; DIBENZOTHIAZEPINE DERIVATIVE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PIPERAZINE DERIVATIVE; QUETIAPINE; RISPERIDONE; SEROTONIN 2A RECEPTOR; THIAZOLE DERIVATIVE; ZIPRASIDONE;

ARTICLE; CHEMICALLY INDUCED DISORDER; CONTROLLED CLINICAL TRIAL; EXTRAPYRAMIDAL SYNDROME; HUMAN; METABOLISM; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; BENZODIAZEPINES; CLOZAPINE; CONTROLLED CLINICAL TRIALS; DIBENZOTHIAZEPINES; HALOPERIDOL; HUMANS; PIPERAZINES; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; RISPERIDONE; SCHIZOPHRENIA; THIAZOLES;

EID: 25644460070     PISSN: 13474367     EISSN: None     Source Type: Journal    
DOI: 10.2133/dmpk.20.187     Document Type: Article

References (0)